Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 -545.7%
March 31, 2026 -531.3%
December 31, 2025 -190.6%
September 30, 2025 -312.7%
June 30, 2025 -1.11K%
March 31, 2025 -737.4%
December 31, 2024 -12.19K%
September 30, 2024 -2.95K%
June 30, 2024 -716.3%
March 31, 2024 -1.61K%
December 31, 2023 -5.24K%
September 30, 2023 61.83%
June 30, 2023 -5.54K%
March 31, 2023 -17.54K%
December 31, 2022 -21.36K%
September 30, 2022 -19.76K%
June 30, 2022 -27.19K%
March 31, 2022 -19.09K%
December 31, 2021 -8.78K%
September 30, 2021 -21.01K%
June 30, 2021 -35.83K%
March 31, 2021 -28.71K%
December 31, 2020 -8.90K%
September 30, 2020 -11.09K%
June 30, 2020 -8.79K%
Date Value
March 31, 2020 -16.05K%
December 31, 2019 -35.22K%
September 30, 2019 -526.4%
June 30, 2019 -814.1%
March 31, 2019 -1.57K%
December 31, 2018 -237.9%
September 30, 2018 -1.05K%
June 30, 2018 -596.7%
March 31, 2018 -728.2%
December 31, 2017 -369.0%
September 30, 2017 -1.23K%
June 30, 2017 -916.9%
March 31, 2017 -1.82K%
December 31, 2016 -369.4%
September 30, 2016 -1.15K%
June 30, 2016 -1.84K%
March 31, 2016 -1.48K%
December 31, 2015 -1.03K%
September 30, 2015 -1.21K%
June 30, 2015 -730.2%
March 31, 2015 -1.08K%
December 31, 2014 -44.36%
September 30, 2014 -1.04K%
June 30, 2014 -577.3%
March 31, 2014 -530.7%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 9.39%
Healios KK --
GNI Group Ltd. 43.49%
Agenus, Inc. -1.64%
Amgen, Inc. 23.59%